Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynectics Regulatory News (SNX)

Share Price Information for Synectics (SNX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 185.00
Bid: 180.00
Ask: 190.00
Change: 2.50 (1.37%)
Spread: 10.00 (5.556%)
Open: 182.50
High: 185.00
Low: 182.50
Prev. Close: 182.50
SNX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

6 Jun 2006 07:02

Synexus Clinical Research PLC06 June 2006 Synexus Clinical Research Plc ("the Company") Directorate change Synexus Clinical Research Plc is pleased to announce the appointment of MalcolmHughes (aged 52) as Non-Executive Director with immediate effect. Malcolm is currently Chief Executive of Greenman Group plc ("Greenman"), aprivate industrial company which supplies printer cartridges to European officesupplies distributors from its manufacturing base in Bulgaria. Prior toGreenman, he was Chief Executive of Oasis Healthcare Plc for four years duringwhich Oasis grew from a small regional business to become the leading dentalpractice owner/operator in the UK with turnover of over £70m. His previousexperience includes senior management roles at Chloride Group plc, LadbrokeGroup plc and Management Consulting Group plc. Commenting on the appointment, Michael Fort, chief executive of Synexus said : " I am delighted to welcome Malcolm to the Synexus board. He brings with himconsiderable knowledge and expertise, not only within the healthcare industrybut also particular experience of business operations within the emergingeconomies of Eastern Europe where Synexus has established a foothold and fromwhich we aim to expand rapidly. We look forward to benefiting from hiscontribution to the development and implementation of our growth strategy." Malcolm Hughes commented: "I am delighted to be joining Synexus at a time when it is seeking to build onits recent AIM flotation through expansion of its operations in the UK andinternationally. Its unique business model offers a strong proposition to globalpharmaceutical companies as they aim to develop more cost-effective methods oftrialling new drug treatments." Additional Information The following is a complete list of Mr Hughes' directorships as required underSchedule 2(g) of the AIM Rules: Current Previous in last 5 yearsGreenman Group plc Oasis Healthcare PlcGreenman UK Limited Oasis Dental Care LimitedGreenman Europe BV The Dencare Management Group LimitedK2 Supplies Limited Dencare Management LimitedPaprika Services Limited Dencare Financial Services LimitedBetforum UK Limited Dencare Developments Limited Dencare Implant Centres Limited Ora Dental Group Holdings Limited Ora Dental Group Limited Ora EBT Trustee Limited Inhoco 978 Limited Inhoco 979 Limited There is no further information required to be disclosed under Schedule 2(g) ofthe AIM Rules. For further information: Michael Fort, Chief Executive, Synexus Clinical Research PLC 01257 230 723 Zoe Biddick, Biddicks 020 7448 1000 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
14th Jun 20065:06 pmRNSIssue of Equity
6th Jun 20067:03 amRNSFinal Results
6th Jun 20067:02 amRNSAcquisition of DUH
6th Jun 20067:02 amRNSDirectorate Change
9th May 20062:31 pmRNSIssue of Equity
21st Apr 20062:15 pmRNSHolding(s) in Company
21st Apr 20067:00 amRNSContract Win
11th Apr 200612:19 pmRNSIssue of Equity
10th Apr 20067:01 amRNSPre-Close Statement
6th Apr 200612:39 pmRNSHolding(s) in Company
30th Mar 20062:30 pmRNSHolding(s) in Company
29th Mar 20063:28 pmRNSHolding(s) in Company
24th Mar 20065:39 pmRNSIssue of Equity
22nd Mar 20065:03 pmRNSDirector/PDMR Shareholding
21st Mar 20064:34 pmRNSIssue of Equity
14th Mar 200610:23 amRNSIssue of Equity
6th Mar 20066:00 pmRNSIssue of Equity
6th Mar 20064:01 pmRNSHolding(s) in Company
28th Feb 20061:34 pmRNSHolding(s) in Company
24th Feb 20064:51 pmRNSHolding(s) in Company
23rd Feb 20065:57 pmRNSIssue of Equity
22nd Feb 20064:21 pmRNSHolding(s) in Company
6th Feb 200610:38 amRNSIssue of Equity
31st Jan 20068:00 amRNSAcquisition
27th Jan 20064:48 pmRNSIssue of Equity
27th Jan 20064:45 pmRNSOffer Update
13th Jan 20065:02 pmRNSIssue of Equity
9th Jan 200612:14 pmRNSIssue of Equity
3rd Jan 20065:28 pmRNSIssue of Equity
20th Dec 20054:32 pmRNSHolding(s) in Company
20th Dec 200512:53 pmRNSDirector/PDMR Shareholding
20th Dec 200512:41 pmRNSDirector/PDMR Shareholding
19th Dec 20053:22 pmRNSDirector/PDMR Shareholding
19th Dec 20052:13 pmRNSTransaction in Own Shares
16th Dec 20053:30 pmRNSIssue of Equity
13th Dec 20055:16 pmRNSIssue of Equity
8th Dec 200510:55 amRNSNotice of Results
8th Dec 20058:23 amRNSStrategic Alliance
5th Dec 20053:02 pmRNSHolding in Company
5th Dec 20052:59 pmRNSShare Allotment
18th Nov 20054:26 pmRNSRecommended Offer for Protec
18th Nov 20057:00 amRNSRe Recommended offer
11th Nov 20052:17 pmRNSHolding(s) in Company
10th Nov 20052:53 pmRNSHolding(s) in Company
9th Nov 20055:03 pmRNSRecommended Offer for Protec
9th Nov 20053:16 pmRNSHolding(s) in Company
7th Nov 20057:00 amRNS First Dealings
4th Nov 20053:46 pmRNSOffer Extended
21st Oct 20055:14 pmRNSOffer Update
21st Oct 20052:10 pmRNSRule 8.3- Quadnetics Group

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.